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ABSTRACT 
Ultraviolet B (UVB) radiation is a modality widely used for the treatment of different skin 
diseases. One of the major mechanisms of UVB immunosuppression in this treatment modality is 
thought to be an apoptosis-inducing effect on T cells infiltrating the skin. We examined the T 
cell apoptosis-induction capacities of 4 different UV light sources, with and without UV filters. 
The xenon chloride (XeCl) laser proved to be the strongest apoptosis-inducer. The use of a 
phtalic acid filter eliminated UV radiation almost completely below 300 rati, which resulted in a 
severe decrease in the apoptosis-inducing capacity of different UVB sources. Using the results of 
the measurements with polychromatic UV light sources, the wavelength dependence of UVB 
light for the induction of T cell apoptosis was also determined. The regression line of the action 
spectrum demonstrated a continuous decrease from 290 ran to 311 nm. The apoptosis-inducing 
capacity of the XeCl laser was almost 4 times higher than the calculated value according to the 
action spectrum, which might be due to the high irradiance of the laser as compared with non-
laser light sources. 
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INTRODUCTION 
Ultraviolet B (UVB) light (280-320 nm) is a modality widely used for the therapy of different 
skin diseases. Initially, broad-band (BB)-UVB light sources were applied in UVB phototherapy, 
these emit w avelengths throughout the whole spectrum of UVB light (1). In 1980, an action 
spectrum study in patients with psoriasis was carried out. With use o f a monochromator, the 
action spectrum for the ultraviolet phototherapy of psoriasis was determined for radiation 
between 254 and 313 nm, and compared with the action spectrum for erythema of the uninvolved 
adjacent skin. Wavelengths of 254, 280 and 290 nm proved to be erythemogenic, but not 
therapeutic even at 10 to 50 times the minimal erythema dose (MED). At wavelengths of 300 
and 304 nm, complete clearing occurred on daily exposure to doses equal to or less than the 
MED. In every subject, suberythemogenic exposure doses of 313 nm resulted in complete 
clearance of the plaques (2). These findings led to the introduction of selective UVB 
phototherapy and narrow-band (NB)-UVB phototherapy. NB-UVB source emits polychromatic 
light, but the 311-313 nm wavelength range predominates in its emission spectrum. In a bilateral 
comparative study, the ability of suberythemogenic doses of NB-UVB versus conventional BB-
UVB to remit psoriasis was compared. NB-UVB radiation proved to be superior to BB-UVB for 
the treatment of psoriasis (3). Since laser light can be selectively directed towards the lesional 
skin, and all of the energy of a 308 nm excimer laser is emitted within the action spectrum for the 
phototherapy o f psoriasis, our group investigated the therapeutic effect of the 308 nm Xenon 
chloride (XeCl) excimer laser for psoriasis. This laser emits its total energy at 308 nm and may 
therefore be regarded as a "super-narrow-band" UVB,light source. The cumulative dose required 
for the complete clearance of psoriatic plaques was 6 times less with the XeCl laser than with 
NB-UVB phototherapy (4). The high clinical efficacy of the XeCl laser for psoriasis was later 
confirmed in other studies (5, 6). The XeCl laser might therefore be regarded as a new and 
promising form of UVB phototherapy, which seems to be superior to conventional UVB sources 
in the treatment of psoriasis and vitiligo (7, 8, 9,10). 
UVB light has been shown to modify cutaneous immune responses, a phenomenon that is called 
photo-immunosuppression (11). Krueger et al. observed that UVB treatment produced a 
consistent and profound depletion of T lymphocytes from psoriatic epidermis. Dermal 
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lymphocytes were much less affected (12). As apoptosis is induced by the in vitro UVB 
irradiation of T cells, it has been proposed that UVB light may have immunosuppressive effects 
in psoriasis through the induction of apoptosis in disease-mediating T cells. Apoptosis, or 
programmed cell death is a physiological suicide mechanism that preserves homeostasis, in 
which cell death naturally occurs during normal tissue turnover (13). To characterize the 
mechanism of T cell depletion, Ozawa et al. applied NB-UVB radiation on peripheral T cells and 
measured the extent of apoptosis. 100 mJ/cm2 NB-UVB light resulted in measurable T cell 
apoptosis by flow cytometry 20 hours later (14). Breuckmann et al. (15) demonstrated delayed 
apoptosis (within 24-48 hours) on human T cells after BB-UVB irradiation also. 
We recently found that XeCl laser is more effective in inducing T cell apoptosis in vitro than 
NB-UVB light, a finding in good agreement with the observed higher clinical efficacy of the 
laser compared with that of the NB-UVB light (16). 
Aims of the study. There is growing evidence that one of the major mechanisms of 
immunosuppression w ith UVB 1 ight i s a n apoptosis-inducing e ffect o n T cells i nfiltrating t he 
skin in inflammatory skin diseases. As different UVB light sources have been used in UVB 
phototherapy with great differences in clinical efficiency, we examined the apoptosis-inducing 
capacities of these UVB lamps. Although much work has been performed on the action spectra 
of UVB radiation for different biological processes, no scientific study appears to have focused 
on the action spectrum of UVB light for the induction of T cell apoptosis. The aim of our study 
was to establish such an action spectrum by using different polychromatic UVB light sources. 
MATERIALS AND METHODS 
UVB light sources. Seven different artificial spectral distribution UVB light were used in the in 
vitro irradiation experiments: an FS20 (Westinghouse, Pittsburgh, PA) lamp without any filter 
(abbreviation: FS20); an FS20 lamp with tissue culture plate top filter (Coming, London, 
England) (abbreviation: FS20+Plastic)*; an NB-UVB (Philips TL01, Philips, Eindhoven, the 
Netherlands) lamp without any filter (abbreviation: TL01); an NB-UVB lamp with 0.055%, 17 
mm thick phtalic acid filter in a pyrex tube (abbreviation: TLOl+phtalic acid)**; an NB-UVB 
lamp with a tissue culture plate top filter (Corning, London, England) (abbreviation: 
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TLOl+Plastic)*; a Solar simulator (Oriel ozone free Xe arc lamp, 2000W, Oriel, Stamford, CT) 
with WG305 filter; 308-nm XeCl excimer laser (Lambda Physik LPX 105 E, Gottingen, 
Germany) without any filter (abbreviation: XeCl). 
*The top of the 24-hole tissue culture plate (Coming, England) was used as a UVB filter. 
**The 35 mm diameter original TL01 tube was placed into a 52 mm diameter pyrex tube and the 
space between the two was filled with 0.055% potassium phthalate which is a UVB filter. The 
phtalic acid filter has to be refilled after 4 hours of use. 
The power of the XeCl laser was metered by an energy detector (Gentec ED-200, Quebec, 
Canada) and a 100 MHz oscilloscope (WATSU Electronic Co. Ltd., Tokyo, Japan). The output 
of the non-laser UVB light sources was metered by a calibrated UVB detector (Laser Precision 
Corp. RT-101, Utica, CA). The irradiance values and incident doses used for irradiation with the 
different UVB light sources are shown in Table 1. The spectral irradiances were determined in 1 
nm steps with a spectroradiometer (Optronic 742). The spectral distribution of the 7 different 
UVB light sources is represented in Figure 1. The absolute spectral irradiance values, indicated 
on the vertical axis, only show values above the noise level of the instrument. 
UVB irradiation in vitro. Peripheral blood mononuclear cells (PBMC) were prepared from 
heparinized venous blood of healthy volunteers by centrifugation over Ficoll-Isopaque gradient. 
The PBMC were washed twice in phosphate-buffered saline (PBS), and then the irradiation was 
performed in uncovered tissue culture plates (Coming, London, England) at a density of 106 
cells/well in 0.3 ml PBS. The preparation of the cells was performed in dark to prevent them 
from accidental photodamage. In order to prevent a warming side-effect, the PBMC were placed 
into a 25 °C water bath during irradiation with a solar simulator. After irradiation, the PBMC 
were washed once in PBS and resuspended in RPMI 1640 (Gibco, Scotland) supplemented with 
10% AB+ heat-inactivated human serum, 2 mM L-glutamine and antibiotics. The cells were 
cultured in a humified 5% CO2 atmosphere at 37 °C for 24 hours. 
Tcell apoptosis detection. T cell apoptosis was detected as described earlier (17). Briefly: PBMC 
were fixed in 2% paraformaldehyde solution for 30 min, washed in PBS and permeabilised in 
0.1% saponin in PBS supplemented with 1% fetal bovine serum and 0.02% NaN3 for 15 min on 
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ice. The cells were then washed in PBS containing 1% BSA, the supernate was discarded, and 
each sample was stained with 20 pi Apo2.7-PE monoclonal antibody (mAb) (Immunotech, Paris, 
France) and 5 pi anti-human CD3-FITC mAb (Dako, Copenhagen, Denmark) in 75 pi PBS for 
25 min at room temperature. To exclude false-positive reactions, control samples were stained 
with isotype-matched anti-human IgGl-PE mAb. After washing, the PBMC were resuspended in 
0.5 ml PBS. 
Flow cytometry. Sample data were acquired on FACStar and FACSCalibur (Becton Dickinson, 
Franklin Lakes, NJ) flow cytometers; 103 events were collected per sample. The samples were 
analyzed by using Cell Quest software (Becton Dickinson, Franklin Lakes, NJ) as described 
earlier (15). Briefly: T cells were selected via anti-CD3 mAb staining, and the Apo2.7 mAb 
binding of these cells was then quantified by histogram analysis. 
Determination of the DNA-weightecl efficiency spectra and the median wavelength values. Using 
the result of the experiments described above, dose-effect curves were created for the induction 
of T cell apoptosis in the case of each light source. The formula for the biologically effective 
dose rate (DNA-weighted efficiency spectra) was calculated applying the recommendation of the 
Commission Internationale d'Éclairage, briefly: 
BED /1=2 E (AÀ.) * S DNA(X) * A X, 
where BED/t is the biologically effective dose rate (DNA-weighted efficiency spectra of a UV 
source), E(X) is the spectral irradiance of the UV source, SDNA(X.) is the action spectrum for UV 
radiation-induced DNA-damage as published by Setlow (18) and AX is the wavelength step from 
spectroradiometric measurements for the determinatio,n of irradiance spectra of the light sources. 
The areas under these DNA-weighted efficiency spectra were calculated with the use of the 
rectangle method, briefly: an area under the curve was distributed to many rectangles of 1 nm of 
width, and the area could has been calculated as the total of the areas of rectangles. The median 
wavelength was determined as the wavelength value which divides the area under the curve into 
two equal parts in the case of each light source. 
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RESULTS 
The T cell apoptosis-inducing capacities of different UVB sources 
In order to establish an action spectrum of UVB for T cell apoptosis-induction, we used different 
spectral distributions of UVB light. The BB-UVB or FS20 lamp, the NB-UVB or TL01 lamp, the 
XeCl laser and the Xe arc solar simulator are well known from the UVB phototherapy of 
different skin diseases. By using a phtalic acid filter with NB-UVB light and by using the plastic 
tissue culture plate top as a filter with FS20 and NB-UVB light, we could create 3 more spectral 
distributions of UVB light. The emission spectra of these 7 UV sources were then determined 
with a spectroradiometer (Fig. 1). PBMC were irradiated in vitro with increasing doses, and T 
cell apoptosis was measured by means of simultaneous Apo2.7 and anti-CD3 stainings with flow 
cytometry. Dose-effect curves were then created. All 7 UVB sources induced T cell apoptosis in 
a dose-dependent manner. Figure 3 represents these dose-effect curves. The dosis necessary to 
induce apoptosis in 50% of the T cells (AD50) was calculated and listed in Table 2. 
TL01 induced apoptosis in 50% of the T cells at a dosis of 300 mJ/cm2; this result is in good 
agreement with our previous experimental data (16). The use of a plastic plate top as a filter 
eliminated most of the short-wavelength UVB radiation. This modification of the spectrum led to 
a decrease in the T cell apoptosis-induction capacity of NB-UVB and FS20. The filtering effect 
of phtalic acid was well observable too: a decrease of about 2 orders of magnitude was found at 
the wavelength 300 nm and phtalic acid eliminated UV radiation almost completely below 300 
nm, which resulted in a severe decrease in the apoptosis-inducing capacity of NB-UVB light 
(AD50: 301 mJ/cm2 and 553 mJ/cm2 without and with phtalic acid filter, respectively). 
FS20 was the most effective of the 6 non-laser UV sources in inducing T cell apoptosis. It 
contains considerable amount of UVC light, and shorter UVB wavelengths predominate in its 
emission spectrum. The elimination of most of this short-wavelength radiation resulted in a 
decrease in its apoptosis-inducing capacity (AD50: 168 mJ/cm and 210 mJ/cm without and 
with plastic filter, respectively). 
The s olar s imulator p roved t o b e t he 1 east e ffective i n i nducing T cell apoptosis. A lthough i t 
contains some UVC light and a considerable amount of UVB radiation, UVA predominates in its 
emission spectrum. The energy density required for the induction of apoptosis in 50% of the T 
cells was 1912 mJ/cm2, which is more than 6 times more than the AD50 for NB-UVB light. 
The 308 nm XeCl laser is a coherent monochromatic pulse-mode UVB excimer laser with a very 
high irradiance (approx. 109 times more than those of the above mentioned non-laser UVB 
sources). The XeCl laser induced T cell apoptosis in a dose-dependent manner too, but 
quantitative induction was much higher than with non-laser UVB sources. The AD50 for the 
XeCl laser was 95 mJ/cm2, this laser light therefore induced apoptosis to a higher degree than did 
any of the non-laser UV sources. 
Determination of the wavelength dependence of T cell apoptosis induction 
One of the major mechanisms of action of UVB light is the induction of T cell apoptosis. It is 
well known that the biological effects of UV light are strongly dependent on the wavelength 
spectrum, though few scientific data exist about the wavelength dependence of T cell apoptosis 
induction. We decided therefore to construct an action spectrum for T cell apoptosis induction in 
the UVB range. The above mentioned 6 different polychromatic 1 ight sources were used and 
dose-effect curves were created by performing the irradiation with increasing energies. Data are 
expressed as the percentages of Apo2.7 and CD3 double-positive cells in relation to all the CD3-
positive cells. The energy densities required for the induction of apoptosis in 50% of the T cells 
were then determined. The apoptosis-inducing capacities of each UV light source were 
calculated by reciprocating the AD50 values (Table 2). DNA damage seems to be the major 
mechanism in the background of UVB radiation-induced T cell apoptosis (15), thus the emission 
spectra of the polychromatic UV sources were weighted by the action spectrum of UV radiation-
induced DNA damage as described above. These DNA-weighted efficiency spectra of the UV 
sources used are presented in Figure 3. The median wavelength values of the areas under the 
curves were calculated and presented in Table 2. For constructing the action spectrum for T cell 
apoptosis induction at polychromatic UVB sources the modification of the method applied in 
(19) was used as follows. The median wavelength value of each UV source has been associated 
with its apoptosis-induction capacity (1/AD50 value) obtained from the dose-effect curves and a 
linear regression curve was calculated. Figure 4 depicts the wavelength dependence of T cell 
apoptosis induction in the range 290 to 311 nm. This regression curve revealed a consistent 
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decrease from shorter to longer wavelengths, e.g. irradiation at 290 nm is 3 times more effective 
in T cell apoptosis induction than that of 311 nm. The real apoptosis inducing capacity of the 
XeCl laser is almost 4 times higher than that calculated on the basis of thisspectrum. 
DISCUSSION 
UV phototherapy is widely applied to treat different dermatoses. The prototypic skin disease 
showing a favorable response to UV phototherapy is psoriasis vulgaris. There is growing 
evidence that the efficacy of UVA and UVB phototherapy may not simply be attributed to 
antiproliferative effects, but most likely involves immunomodulatory consequences (20). One of 
the major mechanisms of action of UVB light in the treatment of inflammatory dermatoses 
seems to be a cytotoxic effect on the infiltrating T cells, where the mechanism of cell death is 
most probably apoptosis. Earlier, psoriatic plaques in 23 patients were treated daily with NB-
UVB or BB-UVB light in a bilateral comparison study. NB-UVB cleared the psoriatic plaques 
more effectively than did BB-UVB light. On the other hand, NB-UVB light has been found to 
be a more potent inductor of T cell apoptosis ex vivo than BB-UVB light; therefore, the T cell 
apoptosis-inducing capacity of a UVB light source can be paralleled by its clinical efficacy. In 
our present study, the in vitro T cell apoptosis-inducing capacities of widely used BB-, NB-UVB 
sources and the XeCl UVB laser were determined and compared with each other. The XeCl laser 
was the strongest apoptosis-inducer, while BB-UVB (FS20) induced T cell apoptosis more 
efficiently than did NB-UVB (TL01). In clinical studies, the XeCl laser also seems to be the 
most efficient antipsoriatic UVB source, suggesting that the more effective induction of T cell 
apoptosis may be responsible for the greater clinical efficacy of the XeCl laser as compared with 
non-laser UVB light. Clinically, however, NB-UVB is a more potent antipsoriatic light source 
than BB-UVB. The main reason for the difference between the in vitro and the clinical data 
might be the absorbance of most of the radiation shorter than 300 nm by the epidermis. Thus, the 
short-wavelength UVB range that is emitted by BB-UVB induces apoptosis efficiently in vitro, 
but cannot penetrate into the dermis. 
Although much scientific work has been carried out on the biological effects of UVB light, little 
is known about the role of optical parameters of radiation in the effect of UVB radiation o n 
biological processes. The DNA-damaging effect of UVB is mediated through cyclobutane 
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pyrimidine dimer and (6-4) photoproduct formation. Matsunaga et al. determined the action 
spectra for the induction of thymine dimers and (6-4) photoproducts in DNA by nearly 
monochromatic UV light ranging from 150 nm to 365 nm. The most efficient wavelength for the 
formation of UV light-induced DNA damage proved to be 260 nm, corresponding to the 
absorption spectrum of DNA (21). Urocanic acid is a major UV chromophore in the upper layers 
of the skin where it is found predominantly as the trans isomer. UVB irradiation induces 
photoisomerisation of trans urocanic acid to cis isomer. Cis urocanic acid is suggested to be a 
mediator of UVB light-induced immunosuppression, because its administration can mimic many 
of the effects of UVB light on the skin (22). Gibbs et al. investigated the wavelength dependence 
for trans-to-cis photoisomerisation in vitro over the spectral range 270-340 nm, and found that 
the resulting action spectra had maximal effectiveness at 300-315 nm (23). The mixed epidermal 
cell lymphocyte reaction (MECLR) and the mixed lymphocyte reaction (MLR) have been 
commonly used to study the immunosuppressive effects of UVB radiation. The alloactivating 
capacity in MLR and MECLR experiments is decreased by exposure to UVB light. Using 
monochromators, Hurks et al. irradiated PBMC with nearly monochromatic UVB light at 254, 
297, 302 and 312 nm, measured the decreases in the MLR and MECLR responses, and hence 
determined the action spectra for the MLR and MECLR from 254 nm to 312 nm. Both the MLR 
and MECLR action spectra displayed a maximum at 254 nm and a relative sensitivity at 312 nm. 
The action spectra were strikingly similar to those for the induction of pyrimidine dimers and 6-4 
photoproducts (24). 
The present study also describes the determination of the wavelength dependence of UVB 
radiation-induced T cell apoptosis. As 95% of the UVC radiation is scattered, reflected and/or 
absorbed in the upper thin (about 25-30 pm) part of the epidermis (25), and UVB was found to 
be superior in biological efficacy than UVA, we restricted the range of our interest to the UVB 
spectrum. The spectral sensitivity for v arious biological UV effects, like killing efficiency of 
simple organisms, production of erythema, DNA damage, skin cancer induction, 
immunosuppression has been determined mostly with monochromatic light [21, .23, 24]. 
However, in this case, the determination of the precise sensitivity value with a monochromatic 
source is somewhat obscure due to the difficulty in determining the accurate light dose (e.g. as 
monochromatic light created by monochromators is of variable and low intensity, the irradiation 
procedure would take hours to induce T cell apoptosis). This fact appears in the literature as the 
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discrepancy between sensitivity curves measured with a monochromatic source and with 
polychromatic radiation observed in normal human skin fibroblasts (26). A precise and 
comprehensive action spectrum determination has been performed earlier [27, 28] for Utrecht-
Philadelphia skin cancer induction on hairless mice using 14 different polychromatic UV 
sources. In the 2 50-400 nm wavelength range the approximation by a Langrange polynomial 
fourth order resulted in a satisfactory fitting of the calculated and the measured data. 
By using different filters with the above-mentioned UV light sources, we could create more 
spectral distribution UV light with higher intensity. Then the efficacy of different spectral 
regions of UVB light to induce T cell apoptosis was determined by the use of these 
polychromatic UV light sources. This experimental method is accepted and proved to be 
successful in photodermatology completed by a polynomial approximation (28). The emission 
spectra of sources used were weighted by the action spectrum of UV radiation-induced DNA 
damage as published by Setlow. The T cell apoptosis-induction capacities of all these lamps 
were determined by the method described earlier. Dose-effect curves were created and the 
apoptosis-induction efficacy (1/AD50) of the UVB sources were calculated by reciprocating the 
dose values which induced apoptosis in 50% of the T cells in the case of each lamp. The 
wavelength dependence of UVB light to induce T cell apoptosis was determined by associating 
the 1/AD50 value with the median wavelength of each light source. The regression curve of this 
"action spectrum" demonstrates a continuous decrease from 290 nm to 311 nm. The decreasing 
trend of this spectrum is similar to those observed earlier, e.g. the erythema action spectrum, the 
action spectrum for thymine dimer and 6-4 photoproduct formation and the action spectra for 
suppression of the MLR and MECLR responses. However, these action spectra (erythema, 
thymine dimer) show several orders of magnitude difference in efficiency between 290-311 nm 
while the "action spectrum" reported here show differences far less than this between these 
wavelengths. The explanation for the similarities might be that all of these processes are 
predominantly mediated by UV light-induced DNA damage. The apoptosis-inducing efficacy of 
the XeCl laser proved to be much higher than those of all of the non-laser sources. The high 
efficacy of the UVB laser was observed in clinical studies too, this super-narrow-band light is 
therefore used more and more widely in phototherapy of different skin diseases. The explanation 
of its very high efficacy is still unknown, but we hypothesize that mainly its high irradiance is 
responsible. Hurks et al. examined the influence of irradiance on the MECLR both in vitro and in 
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vivo using BB-UV lamp with variable UV intensities. They found that the irradiation of 
epidermal cells with high irradiance impaired the alloactivating capacity more than did 
irradiation with low irradiance. They concluded that UVB radiation-induced suppression of 
MECLR was critically dependent on irradiance (29). Our results indicated that the irradiance 
may influence the effects of UVB radiation: higher UVB irradiance can result in a higher level of 
UVB induced immunosuppression. 
As the extent of T cell apoptosis induction and the penetration of UVB light into the dermis is 
wavelength-dependent, the wavelength spectrum of optimal dermato-phototherapy might depend 
on the thickness of the skin lesion. We consider that longer wavelength UVB phototherapy 
would be ideal for the treatment of thick psoriatic plaques, while short-wavelength UVB 
radiation would be optimal for the treatment of thin skin lesions. 
NB-UVB contains considerable amount of short-wavelength UVB light. When phtalic acid filter 
was used, almost all of the radiation shorter than 3 00 nm could be eliminated, however, this 
short-wavelength spectrum was very effective in our in vitro study. Earlier measurements 
disclosed that this short-wavelength-UV light is almost completely absorbed in the upper part of 
the epidermis (30), and therefore cannot induce directly T cell apoptosis in vivo. Thus, the use of 
phtalic acid-filtered UVB light in skin phototherapy might have advantages over traditional UVB 
phototherapy by eliminating the erythema-inducing, but therapeutically not efficient short-
wavelength- UV radiation. However, this hypothesis remains to be proven by in vivo clinical 
studies. 
Although T cell apoptosis induction seems to be the major mechanism of UVB light-induced 
immunosuppression, the results of this study cannot be directly adapted to clinical application. 
We are of the opinion that the spectral distribution of a UVB light source influences the clinical 
results by affecting the apoptosis-induction capacity'and the absorbance and transmittance of the 
light in the epidermis. Light of shorter wavelengths seems to induce T cell apoptosis more 
efficiently; while that of longer wavelengths penetrates better into the dermis. The determination 
of the wavelength dependence of UVB-induced T cell apoptosismight be a small step to the 
improvement of UVB phototherapy. 
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Figure 1. The spectral distribution of the 7 different UVB light sources determined at 1 nm 
steps with a spectroradiometer. The absolute irradiance values, indicated on the vertical axis, 
show values above the noise level of the instrument. 
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UVB source wavelength median (nm) AD50 (mJ/cm2) 1/AD50 (cm2/mJ) 
TL01 2 9 9 301 0 ,0033 
TLOl+phtalic acid 311 553 0 ,0018 
TLOl+plastic 309 420 0 ,0024 
FS20 290 168 0 ,0060 
FS20+plastic 2 9 7 210 0 ,0048 
Solar simulator 299 1912 0 ,0005 
XeCl laser 308 9 5 0 ,0105 
Table 2. The median values of the spectral distribution of UVB sources corrected by the action 
spectrum of UV induced DNA damage (calculated as described in Materials and Methods). The 
AD50 values or the doses necessary to induce apoptosis in 50% of the T cells were calculated 
from the dose-effect curves of each lamp. The apoptosis inducing capacities (1/AD50) of each 
UV light sources were calculated by reciprocating the AD50 values. 
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Abstract 
Earlier we reported that a 308-nm xenon chloride (XeCl) UVB laser is highly effective for treating psoriasis. As ultraviolet B light 
seems to cause T cell apoptosis, in the present study we studied the ability of the XeCl laser to induce T-cell apoptosis in vitro, and then 
compared the apoptosis-inducing capacities of narrow-band UVB (NB-UVB) light and the XeCl laser. The role of laser impulse 
frequency and intensity in the therapeutical and apoptosis-inducing efficacy of XeCl laser was also investigated. Both XeCl laser and 
NB-UVB induced T cell apoptosis, but quantitative induction was greater with XeCl laser. Changes in the frequency and intensity of 
impulses of XeCl laser did not influence its therapeutic and T cell apoptosis-inducing efficacy. These results suggest that the more 
effective induction of T cell apoptosis can be responsible for the greater clinical efficacy of XeCl laser compared to NB-UVB. 
Additionally, the optical properties of the XeCl laser (a monochromatic, coherent, pulse-mode laser; easier precise dosimetry, there are no 
'contaminating' wavelengths) can make this laser light an ideal tool for studies of the mode of action of UVB light. © 2002 Elsevier 
Science B.V. All rights reserved. 
Keywords: Ultraviolet B; Apoptosis; T cells; Psoriasis 
1. Introduction 
Psoriasis vulgaris is a chronic inflammatory skin disease 
that affects 2 -3% of the population. Ultraviolet B (UVB) 
light (290-320 nm) is a widely used therapeutic modality 
for the disease. Initially, broad-band (BB)-UVB light 
sources were applied which emit wavelengths throughout 
the whole spectrum of UVB light. An action spectrum 
study in patients with psoriasis established that at wave-
lengths from 304 to 313 nm suberythemogenic exposure 
doses resulted in complete clearing, while wavelengths 
from 290 to 300 nm produced the sunburn reaction, but 
had no therapeutic benefit []]. These findings led to the 
introduction of the narrow-band (NB)-UVB light source in 
the therapy; this also emits polychromatic light, but the 
311-313 nm wavelength range predominates in its emis-
sion spectrum. In a bilateral comparative study, NB-UVB 
"Corresponding author. 
E-mail address: kl@derma.szote.u-szeged.hu (L. Kemény). 
light proved superior to BB-UVB for the treatment of 
psoriasis [2]. 
Xenon chloride (XeCl) UVB laser treatment is a new 
and promising form of therapy for psoriasis vulgaris [3], 
because all of its energy is emitted within the action 
spectrum for the phototherapy of psoriasis (Fig. 1). This 
laser emits its total energy at 308 nm and may therefore be 
regarded as a 'super narrow band' UVB light source. We 
demonstrated earlier that the cumulative dose required for 
the complete clearance of psoriatic plaques is six times less 
with the XeCl laser than with NB-UVB therapy [3], The 
high clinical efficacy of the XeCl laser for psoriasis was 
later confirmed by other studies [4,5]. The clinical efficacy 
of the XeCl laser in psoriasis is therefore well documented, 
but the mechanism of its high efficacy has not been 
investigated so far. 
There is considerable evidence, that psoriasis vulgaris is 
mediated by activated T-lymphocytes infiltrating the epi-
dermis and the dermo-epidermal interface [6], The major 
mechanism of action of UVB light in the treatment of 
inflammatory dermatoses is the cytotoxic effect on the 
1011-1344 /02 /$ - see front matter © 2002 Elsevier Science B.V. All rights reserved. 
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Fig. I. Emission spectra of NB-UVB (TL01 ) and 308 nm XeCl laser. 
The spectrum of Philips TL01 UVB source was obtained from Modos et 
al. [12], The gray area indicates the most effective wavelengths for the 
phototherapy of psoriasis as measured by Parrish et al. [1]. 
infiltrating T-cells, where the mechanism of cell death is 
most probably apoptosis. NB-UVB light has been found to 
be a more potent inductor of T-cell apoptosis than BB-
UVB light, therefore, the T-cell apoptosis-inducing capaci-
ty of a UVB light source can be paralleled by its clinical 
efficacy [7], 
In the present study, we investigated whether changes of 
the light intensity and impulse frequency of the XeCl laser 
influence its therapeutic efficacy. As UVB light seems to 
cause T-cell apoptosis, we studied the ability of the XeCl 
laser to induce T-cell apoptosis in vitro, and then compared 
the apoptosis-inducing capacities of NB-UVB light and the 
XeCl laser. 
2. Patients and methods 
2.1. Patients 
A total of 48 plaques of 21 patients with chronic plaque 
type psoriasis were treated with XeCl laser phototherapy. 
Informed consent was obtained before the start of the 
study. Upon entry to the study, the patients had not been 
treated with systemic antipsoriatic medication for a mini-
mum of 4 weeks. For each patient, a minimum erythema 
dose (MED) was established in uninvolved, unexposed 
gluteal skin. XeCl laser therapy was given three times 
weekly until the treated plaques had cleared completely. 
The initial dose was 0.6 MED, which was increased by 
20% on each subsequent treatment. A 308-nm XeCl 
excimer laser (Lambda Physik LPX 105 E, Gottingen, 
Germany) was used: its output consisted of a train of short 
pulses (15 ns) at 5.5 mJ/cirT per pulse (the size of the 
light spot is 3 X 3 cm). In two groups of patients, XeCl 
laser phototherapy was performed with different impulse 
intensities (0.06 and 20 mJ/cnT) or impulse frequencies (1 
and 20 Hz), and the cumulative doses and the number of 
treatments up to complete clearance were determined. In 
two groups of patients, symmetrical psoriatic plaques were 
irradiated with the XeCl laser with an impulse frequency 
of 1 or 20 Hz, and local psoriasis severity index (LPSI) [8] 
scores were determined for each plaque following each 
treatment. 
2.2. UVB irradiation in vitro 
Peripheral blood mononuclear cells (PBMC) were pre-
pared from venous blood of healthy volunteers by Ficoll 
sedimentation. The irradiation was performed with the 308 
nm XeCl laser or a 311-nm NB-UVB lamp (Philips TL-01, 
The Netherlands) in uncovered tissue culture plates (10" 
cel ls /well) in phosphate-buffered saline (PBS). For this 
study, laser radiation was delivered at 1 - 4 0 impulses/s. 
The power of the XeCl laser was metered by an energy 
detector (Gentec ED-200, Quebec, Canada) and a 100-
MHz oscilloscope (Watsu Electronic Co. Ltd., Japan) The 
output of the NB-UVB light was metered by a calibrated 
UVB detector (Laser Precision Corp. RT-10 CAL, USA). 
After irradiation, the PBMC were washed once and 
resuspended in RPMI 1640 (Gibco, Scotland) sup-
plemented with 10% A B + heat-inactivated human serum, 
2 mM L-glutamine and antibiotics. The cells were cultured 
at 37 °C in 5% CO, for different time intervals. 
2.3. Detection of apoptotic cells 
2.3.1. TUNEL labeling 
The TUNEL (TdT-mediated dUTP-FITC nick end label-
ing) reaction was performed according to the manufactur-
er's instruction (Boehringer Mannheim, Switzerland). 
Briefly: PBMC were fixed in 4% paraformaldehyde solu-
tion for 30 min, washed twice in PBS, permeabilised in 
0.1% Triton X-100 in 0.1% sodium citrate for 2 min on 
ice, washed twice in PBS containing 1% BSA, the cells 
were then labeled with the TUNEL reaction mixture at 
37 °C for 60 min and anti-CD3-PE monoclonal antibody 
(mAb) (Dako, Denmark) on ice for 15 min. After washing 
in PBS, the cells were resuspended in 0.5 ml PBS. 
2.3.2. Apo2.7 labeling 
PBMC were fixed in 2% paraformaldehyde solution for 
30 min, washed in PBS and permeabilised in 0.1% saponin 
in PBS supplemented with 1% fetal bovine serum and 
0.02% NaN, for 15 min on ice The cells were then 
washed in PBS containing 1% BSA, the supernatant was 
discarded, and each sample was stained with 20 pJ 
Apo2.7-PE mAb (Immunotech, France) and 5 pi anti-
human CD3-FITC mAb (Dako, Denmark) in 75 pi PBS 
for 25 min at room temperature. To exclude false positive 
reactions, control samples were stained with isotype-
matched anti-human IgGl-PE mAb. After washing, cells 
were resuspended in 0.5 ml PBS. 
2.3.3. Flow cytometry 
Sample data were acquired on FACStar and FAC-
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Fig. 3. Flow cytometric analysis of T-cell apoptosis. PBMC were irradiated with increasing amounts of energy from the XeCl laser, and apoptosis was 
assessed 24 h after irradiation. The left panels are untreated controls. The top panels show simultaneous CD3 and Apo2.7 stainings; the upper right 
quadrant indicating apoptotic T-cells. The middle and bottom histograms show only CD3+ T cells, as identified by FITC-CD3 or PE-CD3 staining. The 
abscissa represents the extent of apoptosis, measured with the Apo2.7 or TUNEL method. 
impulse frequencies. We did not find significant differences 
in either of the investigated parameters. 
For most of the plaques, the 3X3-cm light spot of the 
XeCl laser is sufficient for treatment, however we are 
seeking possibilities to extend the area being irradiated at a 
given time. One potential solution would be to mount the 
XeCl laser with a real-time scanner [4]. The scanner would 
perform a total body scan to recognize psoriatic plaques 
and would automatically direct the laser light toward the 
involved areas. However, this technique would result in the 
same plaque receiving irradiation at a reduced impulse 
frequency. Another possibility for total body treatment is if 
the laser light is scattered to increase the area of irradia-
tion. In this case, the light intensity of the laser impulses 
would be reduced. Our present results indicate that the 
introduction of a scanning system or laser light scattering 
would not lower the efficacy of XeCl treatment. 
As UVB acts through the induction of apoptosis on 
different cell types, we set out to learn more about the 
cellular mechanism of action of the XeCl laser, and 
Z. Novâk el al. / Journal of Photochemistry and Photobiology B: Biology 67 (2002) 32-38 37 
A. 
66 niJ/cm 100 mJ/cm2 200 mJ/cm2 300 mJ/cm2 
10 10 
Apo2.7 
B. 
LH <U 
X 
3 
c 
U 
200 400 600 
2 
Irradiation dose (mJ/cm) 
Fig. 5. Comparison of the T-cell apoptosis-inducing capacities of NB-UVB light and the XeCl laser. PBMC were irradiated with increasing amounts of 
NB-UVB light and XeCl laser light. Apoptosis was measured with Apo2.7 staining 24 h after irradiation. All of the histograms show only CD3+ T cells. 
(A) The extent of apoptotic T cells are represented on the abscissa following NB-UVB (upper panels) or XeCl laser (lower panels) irradiation with the same 
energy densities. (B) Summary of three independent experiments. The mean percentage of Apo2.7-positive cells is represented after irradiation with 
increasing amounts of NB-UVB light (triangles) or XeCl UVB laser light (squares). Irradiation with 600 mJ/cm2 XeCl laser induced necrosis of T cells, 
therefore apoptotic changes could not be detected. The paired f-test was performed. P values: * P<0.005, ** P<0.0005. 
Publication III. 
1 2 6 6 CORRESPONDENCE 
References 
1 Coven TR. Burack LH. Guilleaudeau R et al. Narrow band UV-B 
produces superior clinical and histopathological resolution of 
moderate-to-severe psoriasis in patients compared with broadband 
UV-B. Arch Dermatol 1997 : 1 3 3 : 1 5 1 4 - 2 2 . 
2 Gordon PM. Diffey BL. Matthews JN, Farr PM. A randomised 
comparison of narrow-band TL-01 phototherapy and PUVA photo-
chemotherapv for psoriasis. ] Am Acad Dermatol 1999: 4 1 : 7 2 8 - 3 2 . 
3 Tanevv A. Radakovic-Fijan S. Schemper M. Honigsmann H. 
Narrowband UVB phototherapy vs. photochemotherapy in the 
t reatment of chronic plaque-type psoriasis: a paired comparison 
study. Arch Dermatol 1999 : 1 3 5 : 5 1 9 - 2 4 . 
4 Castanet J. Or tonne LP. Physiopathology of vitiligo. Clin Dermatol 
1997: 15: 8 4 5 - 5 1 . 
5 Neumeister P. St runk D. Apfelbeck U et al. Adoptive transfer of 
vitiligo after allogeneic t ransplantat ion for non-Hodgkln's lym-
phoma. Lancet 2 0 0 0 : 3 5 5 : 1 3 3 4 - 5 . 
6 Papavid E. Yu RC. Munn S. Chu AC. Strict anatomical coexistence 
of vitiligo and psoriasis vulgaris - a Koebner phenomenon? Clin Exp 
Dermatol 1996 ; 2 1 : 1 3 8 - 4 0 . 
7 Menter A. Boyd AS. Silverman AK. Guttate psoriasis and vitiligo: 
anatomic cohabitat ion. J Am Acad Dermatol 1989: 20 : 6 9 S - 7 0 0 . 
8 Dhar S. Malakar S. Dhar S. Colocalisation of vitiligo and psoriasis in 
a 9-year-old boy. Pediatr Dermatol 1998: 15: 242-3(Let ter) . 
9 Halcin C. Ftann S-K. Kauh YC. Vitiligo following the resolution of 
psoriatic plaques during PUVA therapy. Int J Dermatol 1997: 36: 
5 3 4 - 6 . 
Repigmentation of localized vitiligo with the xenon 
chloride laser 
SIR. Vitiligo is a common idiopathic acquired disorder of 
unknown cause, which produces disfiguring white patches of 
depigmentation. A large variety of therapeutic agents has 
been tried for its treatment, but no definitive cure is yet 
available. Topical and systemic steroids have been reported to 
display variable efficacy in the treatment of vitiligo.1 The most 
widely used procedure has been phototherapy alone or in 
combination with topical corticosteroids or pseudocatalase.1"' 
One of the most frequently used forms of phototherapy is 
topical psoralen plus ultraviolet (UV) A (PUVA). However, 
there is concern over its long-term effects, especially in 
children, with regard to the increased risks of carcinogenesis 
and premature ageing of the skin. L-Phenvlalanine plus UVA 
treatment has also been reported to lead to a good therapeutic 
effcct in children with extensive vitiligo, but this result was 
not confirmed by others.4 Narrow-band UVB (NB-UVB) 
phototherapy has recently been found to be highly effective 
and well tolerated in both adults and children.5"7 NB-UVB 
therapy has been claimed to have fewer adverse effects 
compared with PUVA therapy. Although insufficient human 
data are available, it has been calculated that long-term 
NB-UVB therapy may involve a lower risk of skin cancer than 
that of PUVA therapy.8 
We recently found that the 308-nm XeCl excimer laser is 
more effective than NB-UVB (311-313 nm) for the treat-
ment of psoriasis, suggesting that this UVB laser might offer 
advantages over NB-UVB.9 The purpose of this study was to 
evaluate the effectiveness of 308-nm XeCl laser phototherapy 
in vitiligo. 
A 24-year-old woman (skin type III) in otherwise excellent 
general health presented with vitiligous patches of several 
years' duration on the elbows. There had been no sponta-
neous repigmentation. She had been treated unsuccessfully 
with topical steroids. Her family history was negative for 
pigmentary disorders. 
We used a 308-nm XeCl excimer laser (Lambda Physics 
LPX 105 E). The energy of each light impulse was 5-5 mj 
cm"", with a duration of 1 5 ns: the diameter of the light spot 
was 3 cm. Irradiation was started at nine impulses, at a rate 
of 20 impulses s"1. The vitiligous patches on the elbows were 
treated three times weekly for 5 weeks initially, then twice 
weekly, never on consecutive days. The initial dose was 49-5 
mj cm" . which was increased by 49-5 mj cm"2 at each 
session. The cumulative dose of irradiation was 70-8 J cm"2. 
During the treatment the eyes were protected with UV-
blocking goggles. Photographs of the elbows were taken 
1 week before the commencement of laser therapy, after 6 
months of treatment, and 3 months following termination of 
the laser therapy. 
Before the treatment, approximately 3-cm diameter com-
pletely white macules were seen on both elbows (Fig. la). 
igure 1. The elbow is shown (a) prior to treatment (b) after 6 months of treatment, and (c) 3 months after termination of the therapy. 
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Repigmentation « as first observed 3 months aftei the start c»f 
the therapy, with pigmented macules of 1 - 3 mm in diameter. 
During the therapy continuous repigmentation was 
subsequently observed, localized to the hair follicles. This 
process led to nearly complete repigmentation of the vitiligous 
areas within 6 months (Fig. lb). Three months after the 
termination of the laser therapy, the repigmentation was 
stable (Fig. lc). No phototoxic or photoallergy reactions, 
perilesional hyperpigmentation or other side-effects were 
observed. Our patient was fully satisfied with the cosmetic 
result. One year after stopping the laser therapy the 
repigmentation is still stable, although relapse is still possible, 
as with other phototherapies. 
In the present study, we found that an XeCl UVB laser was 
highly effective in one patient for the treatment of vitiligo. As 
only the vitiligous areas were treated by UVB. there is little 
risk of carcinogenesis or other UVB side-effects occurring in 
the surrounding skin. Additionally, the absence of perilesional 
hyperpigmentation results in a better cosmetic appearance as 
compared with that attained with other forms of photo-
therapy. We suggest therefore that the 30S-nm UVB excimer 
laser may be a valuable and safe option for vitiligo therapy. 
The mechanism of UV-induced repigmentation is 
unknown. It is likely that, similar to NB-UVB. the 308-nm 
UVB laser exerts immunomodulatory effects and may also 
stimulate the melanocytic reserves in the hair sheaths, as 
repigmentation occurs in a perifollicular pattern. Further 
investigations should be conducted to elucidate the exact 
mechanisms of action. 
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Pulsed dye laser treatment for inflammatory linear 
verrucous epidermal naevus 
SIR. Inflammatory linear verrucous epidermal naevus (ILVEN) 
is the term used to describe epidermal naevi in which 
inflammatory changes are a prominent clinical feature.1 They 
are often not present at birth and appear during the first 
5 years of life, occasionally later. Most appear during the first 6 
months and usually persist, although they may occasionally 
resolve spontaneously. Various treatments have been tried, 
none being entirely satisfactory. The lesions are pruritic 
and often cosmetically unsightly. We report three patients 
with ILVEN, all of whom received successful treatment 
with the pulsed dye laser (Candela SPTL IB. 585 nm). 
Patient 1. An S-year-old boy had extensive ILVEN lesions, 
present since birth, on the right cheek, palm of the right hand 
(including palmar aspects of the index, middle and ring 
fingers) and the right buttock extending down the posterior 
aspect of the leg to the medial side of the great toe (Fig. la). 
Over time, these lesions had extended and become more scaly. 
He had a history of eczema but. apart from his skin problems, 
was otherwise well. Previous treatment included emollients 
and topical steroids of moderate potency. This had caused 
some reduction in the erythema on the cheek but no change 
in the other lesions. 
At 3 years of age laser treatment was commenced. 
Treatment of an initial test area on the right thigh, using 
the pulsed dye laser at 585 nm and 7 J c m - 2 with a 7-mm 
spot size, showed a good response. A more extensive 
treatment was then performed to the right thigh and buttock 
(585 nm. pulse width 0-45 ms. 6-5-7-5 J cm - 2 . 7-mm spot 
size) under general anaesthesia. Following this treatment the 
lesion was smoother and less erythematous, and some areas 
had disappeared totally. A further four treatments were 
performed to the buttock and leg using the same energy 
dose and spaced 6 months-1 year apart. The cheek was 
treated on three occasions (585 nm. pulse width 0-45 ms, 
6-25-6-5 J cm - 2 . 7-mm spot size). The leg showed the best 
response, with resolution of the scaling and erythema, and 
flattening of the lesion (Fig. lb). The face showed some, but 
less marked, improvement. These results were maintained 
over a follow-up period of 2 years. 
Patient 2. A 7-year-old boy had had two lesions of ILVEN 
from birth, one on the palm of the left hand extending to 
the three middle fingers and the other on the media! sole 
of the left foot. He also suffered from cerebral palsy and 
3 2001 British Association of Dermatologists. British fournal of Dermatology. 144. 1262-1295 
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Huntington's disease (HD) is an autosomal dominant neurode-
generative disorder caused by C A G repeat expansion in the 
IT-15 gene coding for huntingtin.. The mechanism of neuronal 
degeneration induced by the mutant" huntingtin is not known. 
Apoptosis may play a role in it. Huntingtin is widely expressed 
in the cells, so abnormalities can be expected also in non-
neural tissue. We examined the susceptibility of lymphocytes 
Key words: Apoptosis; Huntington's disease; Lymphocyte; UVB irradiation 
from H D patients, asymptomatic carriers and normal indivi-
duals to UVB irradiation-induced apopcosis. Lymphocytes from 
eight H D patients and two asymptomatic carriers showed 
increased apoptotic cell death compared to controls. Our 
results suggests that sensitivity of H D cells to induced 
apoptosis is not restricted to neurons. NeuroReport 12:1653-
1656 © 2001 Lippincott Williams & Wilkins. 
INTRODUCTION 
Huntington's disease (HD) is a neurodegenerative disorder 
with autosomal dominant inheritance. The main symptoms 
are choreiform involuntary movements and changes in 
personality culminating in dementia [1]. The characteristic 
neuropathological feature of HD is the selective loss of 
medium-size spiny neurons in the striatum and the loss of 
large cortical neurons in layer VI [2]. The genetic defect is a 
CAG repeat expansion in the IT-15 gene coding for a 
protein with unknown function, named huntingtin [3]. The 
mechanism of cell death induced by the toxic gain of 
function of mutant huntingtin is not known, but there is 
increasing evidence that apoptosis may play an important 
role in neurodegeneration. Apoptotic neurons were de-
tected by TUNEL staining in the neostriatum of HD 
patients [4,5], and activated caspase 8 was identified in 
neuronal intranuclear inclusions in HD brains [6]. This 
suggests that the inclusions composed of polyglutamine 
repeats of huntingtin can induce apoptosis by catalysing 
caspase activation. Mutant huntingtin with polyglutamine 
stretch is cleaved by proapoptotic enzyme caspase 3 
(apopain) [7,8]. Huntingtin is widely expressed throughout 
the CNS as well as in non-neural .tissues, so functional 
abnormalities can be expected also outside of the brain [9]. 
We wanted to know whether non-neural tissue shows 
increased sensitivity to apoptosis. The susceptibility of 
lymphocytes from HD patients, asymptomatic carriers to 
UVB irradiation-induced apoptosis was examined and 
compared to normal controls. 
MATERIALS AND METHODS 
Patients: Peripheral blood mononuclear cells (PBMC) 
were prepared from venous blood of eight HD patiente, 
two asymptomatic carriers and 10 healthy controls by 
FICOLL sedimentation. HD patients were 49.6 ± 15.7 
(mean ± s.d.) years old, asymptomatic carriers were 37 and 
45 years old, control individuals were 45 ± 10.8 years old. 
The number of CAG repeat ranged from 44 to 70 in HD 
patients. The asymptomatic carriers had 43 and 45 CAG 
repeats. All of the patients, asymptomatic carriers and 
controls voluntary participated in the study. The guidlines 
for the molecular genetics predictive testing in HD was 
followed [10]. 
UVB irradiation: For induction of apoptosis PBMC were 
irradiated by XeCl 308 nm UVB laser (Lambda Physik LPX 
105E) in uncovered tissue culture plates in PBS. Laser 
radiation was delivered at 20 Hz, and radiation doses were 
70-200-300 mj. After irradiation the PBMC were washed 
once and suspended in RPMI 1640 (Gibco, Scotland) 
supplemented with 10% AB-i- heat inactivated human 
serum, 2mM r.-glutamine and antibiotics. The cells were 
cultured at 37°C in 5% CCb for 20 h. 
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Immunofluorescence assay for floxu cytometry: PBMC 
we re fixed in 2% paraformaldehyde for 30min , washed in 
PBS and permeabilised in 0.1% saponin in PBS supplemen-
ted with 1% fetal bovine serum and 0.02% N a N î for 15 min 
on ice. The cells were washed in PBS containing 1% BSA, 
the supernate was discarded and each sample was stained 
with 20 pi AP02.7-PE mAb (Immunotech, Marseille, 
France) and 5 pi anti-human CD3-FITC mAb (Dako, Glostr-
up, Denmark) in 75 pi PBS for 25 min at room temperature. 
The AP02.7-PE mAb reacts to a 38kDa mitochondrial 
membrane protein exposed on cells undergoing apoptosis 
[11]. To exclude false positive reactions control samples 
were stained with isotvpe-matched anti-mouse mAb. After 
washing cells were resuspended in 0.5 ml PBS. 
Flow cytometry: Sample data were aquired on FACStar 
and FACSCalibur (Beckton Dickinson, USA) f low cyto-
meter. Samples were analysed using CellQuest software 
(Beckton, Dickinson, USA). The percentage of AP02.7-PE 
positive CD3T lymphocytes were determined. 
Statistical analysis: One-way ANOVA was fol lowed by 
the Fisher's LPSD test to determine significant differences 
between groups, p < 0.05 w a s considered statistically sig-
nificant. 
RESULTS 
Lymphocytes from normal control individuals cultured for 
20 h without UVB irradiation underwent apoptosis to a 
minimal degree. Lymphocytes from HD patients cultured 
in the same condition showed no increased apoptosis 
(3.43%). 
UVB irradiation at an intensity of 70 mj induced apopto-
tic changes in one-fifth of lymphocytes from normal 
individuals cultured exactly in the same condition. Higher 
intensities of irradiation linearly increased the percentage 
of lymphocytes labelled with antibody recognizing apopto-
tic mitochondrial membrane protein. However, the same 
intensities of UVB irradiation of cultured lymphocytes 
from HD patients rendered more lymphocytes to undergo 
apoptotic process than in control groups. Each intensity of 
UVB irradiation applied induced apoptosis in significantly 
higher percentage of lymphocytes from HD patients than 
from normal controls ( p < 0.0171, p < 0.0099, p< 0.0126; 
Fig. 1). 
The reactivity seems to be uniform. All of the samples 
from HD patients exposed to irradiation showed higher 
proportion of apoptotic cells than any of the controls (Fig. 
2). Furthermore the same rate of induced apoptosis was 
noted in the lymphocytes of two asymptomatic carriers of 
HD gene. The enchancement of the apoptotic reaction of 
lymphocytes did not correlate with the rate of H D progres-
sion, or with the stage of the disease. Because of the 
relatively short ranges of CAG repeat expansion (median 
45) in HD patients the rate of apoptotic change in lympho-
cytes could not be correlated reliably with the length of 
CAG repeat expansion. 
DISCUSS ION 
There is a selective neuronal degeneration in the restricted 
patients induced by mutant hunting 
70 mj 200 mj 
UVB irradiation 
300 mj 
O controls • HD patients A carriers 
HD 
Fig. I. 70, 200 and 300mj UVB irradiation-induced apoptotic cell death 
is significandy higher in eight HD patients and two asymptomatic carriers 
compared to ten normal controls. p < 0.0171 (70 mj), p < 0.0099 
(200 mj), p < 0.0126 (300 mj). The points represent the percentage of 
apoptodc cells from each individual. 
pathological process, because huntingtin is widely ex-
pressed in the tissues. This is the second study, which 
proves that in HD not only cells of the central nervous 
system are prone to apoptosis, but also the peripheral 
lymphocytes [12]. We provide further evidence that in-
creased susceptibility of H D cells to apoptosis is not 
restricted to neurons. We used UVB irradiation to induce 
apoptosis in lymphocytes. To monitor the effect immuno-
histochemical detection of Apo2.7 expression in irradiated 
cells was utilized. Sawa et al. [12] applied different meth-
ods (staurosporine exposure) for induction of apoptosis in 
cultured lymphoblasts. In their study the number of cells 
displaying apoptosis markers (DNA laddering, caspase 
assay, depolarization of mitochondria) was doubled in HD 
lymphoblasts cultures. In our present work the same 
tendency of susceptibility of C D 3 + lymphocytes to differ-
ently induced apoptosis was noted. Both sets of experi-
ments however substantiated that under different stress 
conditions higher number of H D lymphocytes react with 
apoptosis. Even having mutant huntingtin the HD lympho-
cytes function normally, because they have much shorter 
lifetime than neurons. The role of huntingtin in the 
apoptotic process is still not clear. Targeted disruption of 
HD gene in mice resulted in embryonic lethality and 
increased apoptosis in the embryonic ectodermal cells 
[13,14]. These data suggest that normal huntingtin has an 
anti-apoptotic effect. The lower incidence of cancer in HD 
patients, but not in their healthy relatives support the 
theory, that mutant huntingtin can protect against cancer 
inducing apoptosis in preneoplastic cells [15]. In vitro 
experiments showed that mutant huntingtin induced neu-
rodegeneration by apoptotic mechanisms in cultured stria-
neurons [16]. Expression of extended polyglutamin 
tin. However, non-neural tissues are also involved in the stretch of huntingtin itself is able to induce apoptosis in 
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Fig. 2. Row cytometric analysis of HD and control lymphocytes labelling with Apo2.7-PE antibody recognizing apoptotic mitochondrial membrane 
protein. Apoptosis was induced by 70 mj, 200 mj and 300 mj UVB Irradiation. The second profile indicates proportion of apoptotic cells within the MI 
region. The UVB Induced apoptosis Is more enchanced in HD patients in each experimental paradigm. 
cell cultures mediated by caspase 8,9,3 activation [17-19]. 
Mutant huntingtin may promote apoptosis in all cell type, 
but only a restricted neuronal subpopulation is the most 
sensitive to this process causing neurodegeneration. 
CONCLUS ION 
Recently investigation has focused on the role of apoptosis 
in neurodegeneration. This study provide a further support 
of that, because, we found an increased susceptibility of 
HD lvmphocytes to apoptosis. The enchanced apoptotic 
process may serve as a therapeutic target for the treatment 
of HD patients and anti-apoptotic factors/drugs such as 
caspase inhibitors, may prevent the asymptomatic carriers 
to develop the symptoms, helping to survive or preserve 
neurons. 
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